"10.1371_journal.pone.0016596","plos one","2011-02-18T00:00:00Z","Andreas Franke; Gerhard J Niederfellner; Christian Klein; Helmut Burtscher","Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany; Pharma Research and Early Development, Roche Glycart AG, Schlieren-ZÃ¼rich, Switzerland","Conceived and designed the experiments: AF GN CK. Performed the experiments: AF. Analyzed the data: AF. Contributed reagents/materials/analysis tools: AF HB. Wrote the paper: AF GN HB.","All authors are employees of Roche. Rituximab is a marketed Roche product. The aim of the study was to get additional insights into the mode of action of anti-CD20 antibodies, which is obviously also in the interest of the authors' employer. The authors confirm that this does not alter their adherence to all the PLoS ONE policies on sharing data and materials.","2011","02","Andreas Franke","AF",4,TRUE,3,1,1,3,TRUE,TRUE,FALSE,0,NA,FALSE
